Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Mayo Clinic
Mayo Clinic
National Cancer Institute (NCI)
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Alliance for Clinical Trials in Oncology
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
University of Southern California
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Children's Oncology Group
Fred Hutchinson Cancer Center
Children's Oncology Group
City of Hope Medical Center
Mayo Clinic
NRG Oncology
City of Hope Medical Center
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
OHSU Knight Cancer Institute
Mayo Clinic
University of Michigan Rogel Cancer Center
University of Rochester
Fred Hutchinson Cancer Center
Mayo Clinic
Northwestern University
Mayo Clinic
City of Hope Medical Center
Mayo Clinic
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
University of California, San Francisco
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center